Reticuloendotheliosis virus (REV) long terminal repeats incorporated in the genomes of commercial fowl poxvirus vaccines and pigeon poxviruses without indication of the presence of infectious REV.
Because of reticuloendotheliosis virus (REV) contamination in commercial poultry vaccines, polymerase chain reaction (PCR) assays have been described to increase the sensitivity of biological assays used to detect REV in vaccines. The PCR assay designed to amplify the long terminal repeat (LTR) region of REV identified REV LTRs in many of the commercial fowl poxvirus (FPV) vaccines evaluated. These commercial vaccines were not thought to be contaminated with replicating REV because of the lack of REV outbreaks, the lack of in vitro amplification, and lack of a serologic response to REV. As previously described, the FPV S vaccine strain is known to carry infectious integrated proviral REV, whereas FPV M vaccine strain and its derivatives carry integrated LTRs or remnants of REV proviral DNA inserted into the FPV genome. Another PCR assay designed to amplify the envelope gene of REV was used to verify that the envelope proviral gene was not present in REV LTR PCR-positive samples. Southern blot analysis with REV LTR probes hybridized to the 9-kb EcoRI genomic fragment of all FPV and pigeon poxviruses evaluated, whereas the envelope probe did not hybridize to any poxvirus genome. Sequence analysis of the 9-kb EcoRI fragment indicated that an integrated REV LTR exists in the 9-kb EcoRI of some poxvirus genomes. A new PCR assay designed to amplify integrated REV LTRs in the 9-kb EcoRI fragment identified complete and incomplete integrated REV LTRs in all FPV and pigeon poxvirus genomes evaluated.
Moore
K M
KM
Biomune Co., Lenexa, KS 66215, USA.
Davis
J R
JR
Sato
T
T
Yasuda
A
A
D000818:Animals; D018150:Avipoxvirus / Q000235:genetics*; D001483:Base Sequence; D015139:Blotting, Southern; D002645:Chickens; D003001:Cloning, Molecular; D010856:Columbidae; D016384:Consensus Sequence; D004279:DNA, Viral / Q000302:isolation & purification; D004340:Drug Contamination; D005587:Fowlpox virus / Q000235:genetics*; D016679:Genome, Viral; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D011533:Proviruses / Q000302:isolation & purification; D015183:Restriction Mapping; D001356:Reticuloendotheliosis virus / Q000235:genetics* / Q000302:isolation & purification; D013047:Specific Pathogen-Free Organisms; D020079:Terminal Repeat Sequences; D014481:United States; D014765:Viral Vaccines / Q000235:genetics*
D004279:DNA, Viral; D014765:Viral Vaccines